MANAGEMENT OF T2DM IN 2017: Clinically relevant results from cardiovascular outcome trials

    loading  Checking for direct PDF access through Ovid

Abstract

The risk of death from cardiovascular causes in people with type 2 diabetes mellitus remains around twice that in the general population, with heart failure a common event. In 2017, results from cardiovascular outcome trials in people with diabetes mellitus showed that some drugs have dual utility — reducing cardiovascular risk and improving glycaemic control.

Related Topics

    loading  Loading Related Articles